-
Disparities in Tardive Dyskinesia Diagnosis and Treatment Among the US Medicare Population
Mar 10, 2025, 14:00 PM -
Are Existing Descriptions of Unmet Medical Need Fit for Purpose in the CMS Drug Negotiation Program Context?
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Regorafenib Versus FTD-TPI + Bevacizumab in Patients with Metastatic Colorectal Cancer from the Perspective of the Brazilian Supplementary Health System
Mar 10, 2025, 14:00 PM -
A Longitudinal Year-by-Year Cost Analysis for Patients Diagnosed with Polycythemia Vera
Mar 10, 2025, 14:00 PM -
Integrating Metrics of Environmental Sustainability into Economic Evaluations: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Enhancing Healthcare Quality through Patient-Centered Outcome Measures in Medicare's Merit-based Incentive Payment System
Mar 10, 2025, 14:00 PM -
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Mar 10, 2025, 14:00 PM -
Are You Still Not Integrating Gen-AI Frameworks in HEOR Workflows? It's No Longer Optional!
Mar 10, 2025, 14:00 PM -
Qualitative Interviews to Characterize Disease and Treatment Burden at Baseline in Adult and Pediatric Patients Participating in a Pivotal Phase 3 Trial of DTX401 for the Treatment of Glycogen Storage Disease Type Ia
Mar 10, 2025, 14:00 PM -
Markov Simulation for Estimating the Impact of Lecanemab Treatment on Health Outcomes in Early Alzheimer's Disease from a Japanese Societal Perspective
Mar 10, 2025, 14:00 PM -
Evaluating the Value of Over-the-Counter Oseltamivir for Influenza: A Cost-Utility Analysis From U.S. Payer and Societal Perspectives
Mar 10, 2025, 14:00 PM -
Millions in Annual National Savings Could Be Realized From Improving the Quality of Uterotonic Medications in Sub-Saharan Africa
Mar 10, 2025, 14:00 PM -
The Quantification of Efficacy and Accuracy for Screening and Data Extraction in Perinatal Mood and Anxiety Disorders Studies: A Comparative Analysis of Traditional vs. GenAI-Powered Approaches
Mar 10, 2025, 14:00 PM -
Impact of Recurrence Modelling on Cost-Effectiveness of New Treatments for Early Cancers
Mar 10, 2025, 14:00 PM -
Disparities in Testing for Mismatch Repair Genes Among Medicare Beneficiaries with Colon Cancer: A Claims-Based Analysis
Mar 10, 2025, 14:00 PM -
Diagnosis and Treatment Journey of Patients With Atrial Fibrillation Prior to Stroke Occurrence
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Axitinib (Caxetib®) as Second-Line Therapy for the Treatment of Metastatic Renal Cell Carcinoma in the National Oncology Institute in Mexico
Mar 10, 2025, 14:00 PM -
Evaluation of Machine Learning Assisted Title and Abstract Screening in 5 Clinical Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)
Mar 10, 2025, 14:00 PM -
Indirect Costs Associated with Diabetic Macular Edema (DME) in Colombia
Mar 10, 2025, 14:00 PM
